Genmab halts patient enrollment for cancer study acquired from Profoundbio acquisition

The study has been halted after just 23 patients. A few months ago, the company cancelled another potential drug acquired through the Profoundbio acquisition.

发布者:BY Linus Calov Jacobsen,转转请注明出处:https://robotalks.cn/genmab-halts-patient-enrollment-for-cancer-study-acquired-from-profoundbio-acquisition/

(0)
上一篇 27 1 月, 2026 2:13 下午
下一篇 27 1 月, 2026 2:18 下午

相关推荐

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。